Multidrug resistant Acinetobacter baumannii: A descriptive study in a city hospital

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Dent, Lemuel L ^a   Marshall, Dana R ^a   Pratap, Siddharth ^a   Hulette, Robert B ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b Nashville General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; CARBAPENEM; CEPHALOSPORIN; IMIPENEM; PENICILLIN G; QUINOLONE DERIVATIVE; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MIXED INFECTION; MULTIDRUG RESISTANCE; NEUROLOGIC DISEASE; NONHUMAN; PSEUDOMONAS; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS; SURGICAL PATIENT; ACINETOBACTER INFECTION; AGED; CROSS INFECTION; DRUG EFFECT; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; URBAN POPULATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, URBAN; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; URBAN POPULATION;

EID: 77954300329     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-196     Document Type: Article

References (19)

1. García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999, 27(9):1794-1799. 10.1097/00003246-199909000-00015, 10507600.
2. Falagas M E, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Critical Care 2007, 11(3):134-136. 10.1186/cc5911, 2206403, 17543135.
3. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai 2009, 92(3):413-419.
4. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006, 55(Pt 12):1615-1617.
5. Kluytmans-Vandenbergh M, Kluytmans J, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005, 5/6:309-313.
6. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: Clinical features, epidemiology, and predictors of mortality. Medicine 1995, 74(6):340-349. 10.1097/00005792-199511000-00004, 7500897.
7. Baran G, Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA. Risk factors for nosocomial imipenem resistant Acinetobacter baumannii infections. Int J Infect Dis 2008, 12(1):16-21. 10.1016/j.ijid.2007.03.005, 17513154.
8. Falagas ME, Kopterides P. Risk factors for the isolation of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systemic review of the literature. J Hosp Inf 2006, 64(1):7-15.
9. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am J Infect Control 2002, 30(7):386-390. 10.1067/mic.2002.122648, 12410214.
10. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, Richet H. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology. Ann of Int Med 1998, 129(3):182-189.
11. Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008, 299(21):2513-2514. 10.1001/jama.299.21.2513, 18523219.
12. Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med 2006, 34(12):2959-2966.
13. Davis KA, Moran KA, McAllister CK, Gray PJ. Multi-drug-resistant Acinetobacter extremity infections in soldiers. Emerg Inf Dis 2005, 11(8):1218-1224.
14. Maragakis LL, Cosgrove SE, Song X, Kim D, Rosenbaum P, Ciesla N, Srinivasan A, Ross T, Carroll K, Perl TM. An Outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004, 292(24):3006-3011. 10.1001/jama.292.24.3006, 15613669.
15. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
16. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar AE, García-Garmendia JL, Bernabeu-WittelI M, Gallego-Lara SL, Madrazo-Osuna J. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin Infect Dis 2003, 36:1111-1118. 10.1086/374337, 12715304.
17. Aybar Türkoǧlu M, Topeli Iskit A. Ventilator associated pneumonia caused by high risk microorganisms: a matched case control study. Tuberk Toraks 2008, 56(2):139-149.
18. Mai MH, Tsai HC, Lee SS, Wang YH, Chen YS, Wann SR, Liu YC. Multi-drug-resistant Acinetobacter baumannii in ventilator-associated pneumonia at a medical center in southern Taiwan. J Microbiol Immunol Infect 2007, 40(5):401-405.
19. Peleg AY, Seifert H, Paterson D. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin Microbiol Reviews 2008, 538-582.